Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
5.05
0.01 (0.20%)
At close: May 02, 2025, 3:59 PM
4.99
-1.29%
After-hours: May 02, 2025, 04:05 PM EDT
Avalo Therapeutics Revenue
Avalo Therapeutics reported an annual revenue of $441K, reflecting a -77.08% growth. For the quarter ending December 31, 2024, Avalo Therapeutics generated $192K in revenue.
Revenue (ttm)
$441K
Revenue Growth
-77.08%
Price / Sales Ratio
136.95
Revenue / Employee
$19.17K
Employees
23
Market Cap
53.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|